Rare cardiac tumor

Rare cardiac tumors are an uncommon group of neoplasms that arise within the heart or its surrounding structures (pericardium). These tumors can be primary (originating in the heart) or may present as isolated rare subtypes not classified under more common cardiac tumor categories. Primary cardiac tumors are exceedingly rare, with the majority being benign (such as myxomas, rhabdomyomas, fibromas, and lipomas), while a smaller proportion are malignant (such as sarcomas and primary cardiac lymphomas). These tumors affect the cardiovascular system and can interfere with normal heart function depending on their size, location, and growth pattern. Clinical manifestations of rare cardiac tumors are highly variable and depend on the tumor's position within the heart. Symptoms may include heart failure, arrhythmias, chest pain, syncope (fainting), dyspnea (shortness of breath), embolic events (such as stroke or peripheral embolism), pericardial effusion, and constitutional symptoms like fever, weight loss, and fatigue. Some tumors may be asymptomatic and discovered incidentally during cardiac imaging. Obstructive tumors can mimic valvular heart disease, while infiltrative tumors may cause conduction abnormalities. Diagnosis typically involves echocardiography, cardiac MRI, and CT imaging, with histopathological confirmation often required. Treatment depends on the tumor type and may include surgical resection, which is the primary approach for most benign and some malignant cardiac tumors. Chemotherapy and radiation therapy may be used for malignant tumors, though outcomes for primary malignant cardiac tumors remain poor. Multidisciplinary management involving cardiologists, cardiothoracic surgeons, and oncologists is essential. Given the rarity and heterogeneity of these tumors, treatment is often individualized, and clinical trial participation may be considered when available.

Common questions about Rare cardiac tumor